Chiron Behring

Email Address

feedback@chironbehring.com

Phone Number

+91-2646-253078

Enquiry
  • Home
  • Leadership

Dr. Raches Ella brings a unique blend of scientific expertise and leadership to the field of global health. As the Managing Director of Sapigen Biologix, a vaccine manufacturing facility in Bhubaneswar with an investment of Rs 1500 crore, he oversees the advancement and production of vaccines for critical diseases such as Cholera, RTSS, Malaria, and Zika.

Under his leadership, Sapigen Biologix is positioned to make a significant contribution to addressing global health challenges. Its focus is on operational efficiency and innovation, and it fosters a positive work culture.

In his role as Chief Development Officer at Bharat Biotech, Dr. Raches leads the Global Product Development division, guiding the development of vaccines and therapeutics with an emphasis on safety, regulatory compliance, and scientific integrity. His work involves building collaborations with global health organizations, such as GAVI, WHO, and UNICEF, to ensure that the company’s products reach those in need, especially in underserved regions.

Dr. Raches played a pivotal role in the development of COVAXIN and iNCOVACC, two important vaccines during the COVID-19 pandemic that helped address the global health crisis. His experience leading these projects reflects his commitment to public health and his ability to navigate complex challenges in vaccine development.

With a background in medicine and research, Dr. Raches has contributed to several notable publications in medical journals such as *The Lancet* and *Nature*. His work spans biological product development, clinical research, and business strategy, offering practical solutions to improve health outcomes on a global scale.

Dr. Raches holds an MBA from Harvard Business School, a master’s in clinical research from Emory University, a Postdoctoral Fellowship from Johns Hopkins Bloomberg School of Public Health, and a Doctor of Medicine degree from Sri Ramachandra Medical College. His diverse expertise and collaborative approach continue to shape his contributions to the field of global health.

Sai Prasad holds an undergraduate degree in biochemistry from the University of Wisconsin (USA) and an MBA in Finance and Marketing from the University of Iowa (USA). His publications and patents span vaccines, biotechnology, human genetics, cell biology, and molecular biology. Prior to joining Bharat Biotech, he successfully established clinical diagnostics (molecular genetics) GLP laboratories at the University of Iowa.

Since 2004, he has been with Bharat Biotech, developing several vaccines and biologics, including ROTAVAC®, TYPBAR TCV®, JENVAC®, COVAXIN®, iNCOVACC®, etc., most of which are now global products. He is an integral part of building Bharat Biotech into a global vaccine major with multiple manufacturing sites within India and global vaccine supplies.

His current position as Executive Director entails management of manufacturing operations, business development, strategy and international collaborations within the company. As a well-rounded professional, he has extensive experience in clinical development, media relations, contract negotiations, in-licensing, out-licensing, mergers & acquisitions, funding raising, budgeting, project proposals, human resources management, operations, etc.,

During his tenure as President of Quality Operations at Bharat Biotech, he supervised all aspects of quality management, including quality assurance, quality control, and quality management systems. These activities were intended to develop a strong quality culture and ensure a safe, effective product, allowing the product to reach a global audience.

As vice President at Bharat Biotech, he oversaw several departments, including Business Development, Project Management, Information Systems, and Global Strategic Initiatives. He has extensive experience in vaccines and biologics as a product development and commercialisation manager. With unique skills, knowledge, and expertise, Mr. Sai Prasad bridges science to business and global cultures.